JBIO insider transactions
Jade Biosciences Inc. (JBIO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for JBIO
- Chief Financial Officer Dahms Bradford D. was granted 37,813 shares (SEC Form 4)4 - Jade Biosciences, Inc. (0001798749) (Issuer)
- Officer Balta Elizabeth was granted 28,125 shares (SEC Form 4)4 - Jade Biosciences, Inc. (0001798749) (Issuer)
- Chief Executive Officer Frohlich Tom was granted 78,750 shares, increasing direct ownership by 1,039% to 86,331 units (SEC Form 4)4 - Jade Biosciences, Inc. (0001798749) (Issuer)
- Officer King Andrew James was granted 41,250 shares, increasing direct ownership by 12% to 386,113 units (SEC Form 4)4 - Jade Biosciences, Inc. (0001798749) (Issuer)
- Director Fairmount Funds Management Llc was granted 1,333,126 shares (SEC Form 4)4 - Jade Biosciences, Inc. (0001798749) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Dahms Bradford D.4 - Jade Biosciences, Inc. (0001798749) (Issuer)
- SEC Form 3 filed by new insider Dahms Bradford D.3 - Jade Biosciences, Inc. (0001798749) (Issuer)
- Chief Executive Officer Frohlich Tom bought $44,400 worth of shares (6,000 units at $7.40) (SEC Form 4)4 - Jade Biosciences, Inc. (0001798749) (Issuer)